QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
(This article is prepared for QUEST readers from a study published in the Journal of Clinical Oncology and introduces readers to a vocabulary important for interpreting recent numbers on prostate cancer screening and prostate cancer mortality.) “If you don’t do…
This article is based upon a study* supported in part by the URF and presented at a recent American Urological Association meeting. PSA is the long-standing and accepted method for early detection of prostate cancer and for recommendation of biopsies;…
In December, 2010 an FDA advisory panel met to evaluate two proposals for the use of 5a reductase inhibitors to reduce the risk of prostate cancer. The panel rejected both voting 17-0 with one abstention that the risks of Proscar…
The two companies presented results of clinical trials claiming the drugs reduce the risk of prostate cancer. However, in both studies, men who took these drugs for several years had a higher rate of the potentially lethal high-grade prostate cancers….
Blood clots are a cause for concern after invasive surgery and patients are often prescribed low doses of heparin to prevent them; yet, there is no consensus for such a recommendation with a radical prostatectomy (RP). Our study* looked at…
(This article is prepared for QUEST readers from a study* presented at a recent AUA meeting.) Despite considerable refinement in radical prostatectomy and radiation therapy over the past few decades, all treatments for prostate cancer proceed as if a patient’s…
The Nanotechnology PSA test described in this material is not commercially available at the present. We include the information to keep readers informed about the latest research in which Dr. Catalona, his research collaborators and the URF are involved and…
Men with low-risk prostate cancer (CaP) have multiple options for treatment including radical prostatectomy (RP), radiation therapy and active surveillance. Increased acceptance of surveillance, scheduling issues, time spent on researching various options, and other circumstances may lead to extended time…
When Don was diagnosed, he had just joined Safeway, and was on his way from California to Chicago to become President of the company’s Dominick’s Supermarket chain. Fortunately for Don, Safeway is a committed supporter of prostate cancer research. The…
After a decade of being abandoned, the implantation of radioactive seeds for prostate cancer has become popular again and is being marketed aggressively in many places. Implantation of radioactive seeds was first popularized in the 1970s, but the long-term results…
"*" indicates required fields
